MYC and cancer: Ninomiya et al. [26] reported that excess reactivity to c-myc product occurred more frequently in invasive cancers than in localized cancers, and c-myc production expression in cancer tissue correlated well with peritoneal dissemination, and patients with c-myc positive expression had poorer prognosis than those with c-myc negative expression.